Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS One. 2009 Dec 1;4(12):e8103. doi: 10.1371/journal.pone.0008103.
PDZK1 is a four PDZ-domain containing protein that binds to the carboxy terminus of the HDL receptor, scavenger receptor class B type I (SR-BI), and regulates its expression, localization and function in a tissue-specific manner. PDZK1 knockout (KO) mice are characterized by a marked reduction of SR-BI protein expression ( approximately 95%) in the liver (lesser or no reduction in other organs) with a concomitant 1.7 fold increase in plasma cholesterol. PDZK1 has been shown to be atheroprotective using the high fat/high cholesterol ('Western') diet-fed murine apolipoprotein E (apoE) KO model of atherosclerosis, presumably because of its role in promoting reverse cholesterol transport via SR-BI.
Here, we have examined the effects of PDZK1 deficiency in apoE KO mice fed with the atherogenic 'Paigen' diet for three months. Relative to apoE KO, PDZK1/apoE double KO (dKO) mice showed increased plasma lipids (33% increase in total cholesterol; 49 % increase in unesterified cholesterol; and 36% increase in phospholipids) and a 26% increase in aortic root lesions. Compared to apoE KO, dKO mice exhibited substantial occlusive coronary artery disease: 375% increase in severe occlusions. Myocardial infarctions, not observed in apoE KO mice (although occasional minimal fibrosis was noted), were seen in 7 of 8 dKO mice, resulting in 12 times greater area of fibrosis in dKO cardiac muscle.
These results show that Paigen-diet fed PDZK1/apoE dKO mice represent a new animal model useful for studying coronary heart disease and suggest that PDZK1 may represent a valuable target for therapeutic intervention.
PDZK1 是一种含有四个 PDZ 结构域的蛋白质,可与 HDL 受体、清道夫受体 B 型 I(SR-BI)的羧基末端结合,并以组织特异性的方式调节其表达、定位和功能。PDZK1 敲除(KO)小鼠的肝脏中 SR-BI 蛋白表达明显减少(约 95%)(其他器官减少或无减少),同时血浆胆固醇增加 1.7 倍。PDZK1 已被证明在高脂/高胆固醇(“西方”)饮食喂养的载脂蛋白 E(apoE)KO 动脉粥样硬化小鼠模型中具有抗动脉粥样硬化作用,推测是因为其通过 SR-BI 促进胆固醇逆向转运。
在这里,我们研究了 PDZK1 缺乏对用致动脉粥样硬化的“Paigen”饮食喂养三个月的 apoE KO 小鼠的影响。与 apoE KO 相比,PDZK1/apoE 双敲除(dKO)小鼠的血浆脂质增加(总胆固醇增加 33%;未酯化胆固醇增加 49%;磷脂增加 36%),主动脉根部病变增加 26%。与 apoE KO 相比,dKO 小鼠表现出严重的冠状动脉阻塞性疾病:严重阻塞增加 375%。apoE KO 小鼠未观察到心肌梗死(尽管偶尔注意到最小程度的纤维化),但在 8 只 dKO 小鼠中有 7 只出现心肌梗死,导致 dKO 心肌纤维化面积增加 12 倍。
这些结果表明,用 Paigen 饮食喂养的 PDZK1/apoE dKO 小鼠代表了一种用于研究冠心病的新动物模型,并表明 PDZK1 可能是治疗干预的有价值的靶点。